The book of opposites: The role of the nuclear receptor co-regulators in the suppression of epidermal genes by retinoic acid and thyroid hormone receptors

Journal of Investigative Dermatology

Volumn 124, Issue 5, 2005, Pages 1034-1043

  Jho, Sang H ^a   Vouthounis, Constantinos ^a   Lee, Brian ^a   Stojadinovic, Olivera ^a   Im, Mark J ^a   Brem, Harold ^b   Merchant, Ankit ^a   Chau, Katherine ^a   Tomic Canic, Marjana ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Columbia Univ Coll Phys Surgs ^*  (United States)

Author keywords

Co activators; Co repressors; Epidermal keratin genes; Retinoids; Thyroid hormone

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; HISTONE DEACETYLASE INHIBITOR; KERATIN; NUCLEAR RECEPTOR COREPRESSOR; RETINOIC ACID; THYROID HORMONE RECEPTOR; TRICHOSTATIN A;

ARTICLE; CONTROLLED STUDY; EPIDERMIS; GENE CONTROL; GENE REPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TISSUE SPECIFICITY; TRANSCRIPTION REGULATION;

EID: 18244384707     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0022-202X.2005.23691.x     Document Type: Article

References (62)

1. Blumenberg M: Keratinocytes biology and differentiation. In: Arndt KP (ed). Cutaneous Medicine and Surgery, Vol. 1. Philadelphia: W.B. Saunders, 1996; p 58-74
2. Chang HM, Paulson M, Holko M, Rice CM, Williams BR, Marie I, Levy DE: Induction of interferon-stimulated gene expression and antiviral responses require protein deacetylase activity. Proc Natl Acad Sci USA 101:9578-9583, 2004
3. Chen CA, Okayama H: Calcium phosphate-mediated gene transfer: A highly efficient transfection system for stably transforming cells with plasmid DNA. Biotechniques 6:632-638, 1988
4. Claessens F, Verrijdt G, Schoenmakers E, Haelens A, Peeters B, Verhoeven G, Rombauts W: Selective DNA binding by the androgen receptor as a mechanism for hormone-specific gene regulation. J Steroid Biochem Mol Biol 76:23-30, 2001
5. Coulombe PA, Omary MB: "Hard" and "soft" principles defining the structure, function and regulation of keratin intermediate filaments. Curr Opin Cell Biol 14:110-122, 2002
6. Epstein JH: Effects of retinoids on ultraviolet-induced carcinogenesis. J Invest Dermatol 77:144-146, 1981
7. Fass DM, Butler JE, Goodman RH: Deacetylase activity is required for cAMP activation of a subset of CREB target genes. J Biol Chem 278:43014-43019, 2003
8. Fisher C, Blumenberg M, Tomic-Canic M: Retinoid receptors and keratinocytes. Crit Rev Oral Biol Med 6:284-301, 1995
9. Fisher GJ, Esmann J, Griffiths CE, et al: Cellular, immunologic and biochemical characterization of topical retinoic acid-treated human skin. J Invest Dermatol 96:699-707, 1991
10. Fisher GJ, Voorhees JJ: Molecular mechanisms of retinoid actions in skin. FASEB J 10:1002-1013, 1996
11. Fondell JD, Ge H, Roeder RG: Ligand induction of a transcriptionally active thyroid hormone receptor coactivator complex. Proc Natl Acad Sci USA 93:8329-8333, 1996
12. Futoryan T, Gilchrest BA: Retinoids and the skin. Nutr Rev 52:299-310, 1994
13. Garcia-Villalba P, Jimenez-Lara AM, Castillo AI, Aranda A: Histone acetylation influences thyroid hormone and retinoic acid-mediated gene expression. DNA Cell Biol 16:421-431, 1997
14. Gilfix BM, Eckert RL: Coordinate control by vitamin A of keratin gene expression in human keratinocytes. J Biol Chem 260:14026-14029, 1985
15. Gronemeyer H, Miturski R: Molecular mechanisms of retinoid action. Cell Mol Biol Lett 6:3-52, 2001
16. Heinzel T, Lavinsky RM, Mullen TM, et al: A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression [see comments]. Nature 387:43-48, 1997
17. Heymann WR: Advances in the cutaneous manifestations of thyroid disease. Int J Dermatol 36:641-645, 1997
18. Holt PJ, Marks R: The epidermal response to change in thyroid status. J Invest Dermatol 68:299-301, 1977
19. Hong H, Kohli K, Garabedian MJ, Stallcup MR: GRIP1, a transcriptional coactivator for the AF-2 transactivation domain of steroid, thyroid, retinoid, and vitamin D receptors. Mol Cell Biol 17:2735-27344, 1997
20. Isseroff RR, Chun KT, Rosenberg RM: Triiodothyronine alters the cornification of cultured human keratinocytes. Br J Dermatol 120:503-510, 1989
21. Jenster G, Spencer TE, Burcin MM, Tsai SY, Tsai MJ, O'Malley BW: Steroid receptor induction of gene transcription: A two-step model. Proc Natl Acad Sci USA 94:7879-7884, 1997
22. Jho SH, Radoja N, Im MJ, Tomic-Canic M: Negative response elements in keratin genes mediate transcriptional repression and the cross-talk among nuclear receptors. J Biol Chem 276:45914-45920, 2001
23. Jiang CK, Connolly D, Blumenberg M: Comparison of methods for transfection of human epidermal keratinocytes. J Invest Dermatol 97:969-973, 1991
24. Khan OY, Nawaz Z: Nuclear hormone receptor co-regulators. Curr Opin Drug Discov Dev 6:692-701, 2003
25. Klampfer L, Huang J, Swaby LA, Augenlicht L: Requirement of histone deacetylase activity for signaling by STAT1. J Biol Chem 279:30358-30368, 2004
26. Kraemer KH, DiGiovanna JJ, Peck GL: Chemoprevention of skin cancer in xeroderma pigmentosum. J Dermatol 19:715-718, 1992
27. Lee B, Vouthounis C, Stojadinovic O, Brem H, Im MJ, Tomic-Canic M: From an enhanceosome to a repressosome: Molecular antagonism between glucocorticoids and EGF leads to inhibition of wound healing. J Mol Biol 345:1083-1097, 2005
28. Li X, Kimbrel EA, Kenan DJ, McDonnell DP: Direct interactions between corepressors and coactivators permit the integration of nuclear receptor-mediated repression and activation. Mol Endocrinol 16:1482-1489, 2002
29. Lichti U, Ben T, Yuspa SH: Retinoic acid-induced transglutaminase in mouse epidermal cells is distinct from epidermal transglutaminase. J Biol Chem 260:1422-1426, 1985
30. Lotan R: Retinoids and their receptors in modulation of differentiation, development, and prevention of head and neck cancers. Anticancer Res 16:2415-2419, 1996
31. Magnaldo T, Bernerd F, Asselineau D, Darmon M: Expression of loricrin is negatively controlled by retinoic acid in human epidermis reconstructed in vitro. Differentiation 49:39-46, 1992
32. Mahajan MA, Das S, Zhu H, Tomic-Canic M, Samuels HH: The nuclear hormone receptor co-activator NRC is a pleiotropic modulator affecting growth, development, apoptosis, reproduction, and wound repair. Mol Cell Biol 24:4994-5004, 2004
33. Mangelsdorf DJ, Thummel C, Beato M, et al: The nuclear receptor super-family: The second decade. Cell 83:835-839, 1995
34. McKenna NJ, Xu J, Nawaz Z, Tsai SY, Tsai MJ, O'Malley BW: Nuclear receptor coactivators: Multiple enzymes, multiple complexes, multiple functions. J Steroid Biochem Mol Biol 69:3-12, 1999
35. Montminy M: Transcriptional activation. Something new to hang your HAT on. Nature 387:654-655, 1997
36. Moon TE, Levine N, Cartmel B, et al: Design and recruitment for retinoid skin cancer prevention (SKICAP) trials. The Southwest Skin Cancer Prevention Study Group. Cancer Epidemiol Biomarkers Prev 4:661-669, 1995
37. Nagy L, Kao HY, Chakravarti D, et al: Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase. Cell 89:373-380, 1997
38. Ogryzko VV, Schiltz RL, Russanova V, Howard BH, Nakatani Y: The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87:953-959, 1996
39. Pearce D, Matsui W, Miner JN, Yamamoto KR: Glucocorticoid receptor transcriptional activity determined by spacing of receptor and nonreceptor DNA sites. J Biol Chem 273:30081-30085, 1998
40. Radoja N, Diaz DV, Minars TJ, Freedberg IM, Blumenberg M, Tomic-Canic M: Specific organization of the negative response elements for retinoic acid and thyroid hormone receptors in keratin gene family. J Invest Dermatol 109:566-572, 1997
41. Radoja N, Komine M, Jho SH, Blumenberg M, Tomic-Canic M: Novel mechanism of steroid action in skin through glucocorticoid receptor monomers. Mol Cell Biol 20:4328-4339, 2000
42. Randolph RK, Simon M: Characterization of retinol metabolism in cultured human epidermal keratinocytes. J Biol Chem 268:9198-9205, 1993
43. Reuning U, Wilhelm O, Nishiguchi T, Guerrini L, Blasi F, Graeff H, Schmitt M: Inhibition of NF-kappa B-Rel A expression by antisense oligodeoxynucleotides suppresses synthesis of urokinase-type plasminogen activator (uPA) but not its inhibitor PAl-1. Nucleic Acids Res 23:3887-3893, 1995
44. Ricci AR, Genereaux J, Brandl CJ: Components of the SAGA histone acetyltransferase complex are required for repressed transcription of ARG1 in rich medium. Mol Cell Biol 22:4033-4042, 2002
45. Rosenberg RM, Isseroff RR, Ziboh VA, Huntley AC: Abnormal lipogenesis in thyroid hormone-deficient epidermis. J Invest Dermatol 86:244-248, 1986
46. Rosenthal DS, Griffiths CE, Yuspa SH, Roop DR, Voorhees JJ: Acute or chronic topical retinoic acid treatment of human skin in vivo alters the expression of epidermal transglutaminase, loricrin, involucrin, filaggrin, and keratins 6 and 13 but not keratins 1, 10, and 14. J Invest Dermatol 98:343-350, 1992
47. Safer JD, Crawford TM, Fraser LM, et al. Thyroid hormone action on skin: Diverging effects of topical versus intraperitoneal administration. Thyroid 13:159-165, 2003
48. Sakamoto S, Potla R, Larner AC: Histone deacetylase activity is required to recruit RNA polymerase II to the promoters of selected interferon stimulated early response genes. J Biol Chem 279:40362-40367, 2004
49. Shang Y, Myers M, Brown M: Formation of the androgen receptor transcription complex. Mol Cell 9:601-610, 2002
50. Spencer TE, Jenster G, Burcin MM, et al: Steroid receptor coactivator-1 is a histone acetyltransferase. Nature 389:194-198, 1997
51. Steijlen PM, Reifenschweiler DO, Ramaekers FC, et al: Topical treatment of ichthyoses and Darier's disease with 13-cis-retinoic acid. A clinical and immunohistochemical study. Arch Dermatol Res 285:221-226, 1993
52. Stellmach V, Leask A, Fuchs E: Retinoid-mediated transcriptional regulation of keratin genes in human epidermal and squamous cell carcinoma cells. Proc Natl Acad Sci USA 88:4582-4586, 1991
53. Tomic M, Jiang CK, Epstein HS, Freedberg IM, Samuels HH, Blumenberg M: Nuclear receptors for retinoic acid and thyroid hormone regulate transcription of keratin genes. Cell Regul 1:965-973, 1990
54. Tomic-Canic M, Freedberg IM, Blumenberg M: Codominant regulation of keratin gene expression by cell surface receptors and nuclear receptors. Exp Cell Res 224:96-102, 1996
55. Tomic-Canic M, Sunjevaric I, Freedberg IM, Blumenberg M: Identification of the retinoic acid and thyroid hormone receptor-responsive element in the human K14 keratin gene. J Invest Dermatol 99:842-847, 1992
56. Torchia J, Rose DW, Inostroza J, Kamei Y, Westin S, Glass CK, Rosenfeld MG: The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function. Nature 387:677-684, 1997
57. Van Tilborg MA, Lefstin JA, Kruiskamp M, Teuben J, Boelens R, Yamamoto KR, Kaptein R: Mutations in the glucocorticoid receptor DNA-binding domain mimic an allosteric effect of DNA. J Mol Biol 301:947-958, 2000
58. Vietor I, Oliveira IC, Vilcek J: CCAAT box enhancer binding protein alpha (C/EBP-alpha) stimulates kappaB element-mediated transcription in transfected cells. J Biol Chem 271:5595-5602, 1996
59. Vom Baur E, Zechel C, Heery D, et al: Differential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1. EMBO J 15:110-124, 1996
60. Wong J, Shi YB, Wolffe AP: Determinants of chromatin disruption and transcriptional regulation instigated by the thyroid hormone receptor: Hormone-regulated chromatin disruption is not sufficient for transcriptional activation. EMBO J 16:3158-3171, 1997
61. Wong P, Coulombe PA: Loss of keratin 6 (K6) proteins reveals a function for intermediate filaments during wound repair. J Cell Biol 163:327-337, 2003
62. Yamamoto KR, Darimont BD, Wagner RL, Iniguez-Lluhi JA: Building transcriptional regulatory complexes: Signals and surfaces. Cold Spring Harb Symp Quant Biol 63:587-598, 1998